Valuation: Aprogen Biologics Inc.

Market Cap 2.53TCr 1.88Cr 1.67Cr 1.56Cr 1.42Cr 2.68Cr 180.68Cr 2.7Cr 19Cr 7.31Cr 92Cr 7.06Cr 6.9Cr 296.44Cr P/E 2024
-0.79x
P/E 2025 -0.6x
Enterprise Value 20TCr 15Cr 13Cr 12Cr 11Cr 21Cr 1.45TCr 22Cr 150.88Cr 58Cr 738.85Cr 56Cr 55Cr 2.37TCr EV / Sales 2024
3.66x
EV / Sales 2025 3.82x
Free-Float
43.05%
Yield 2024 *
-
Yield 2025 -
1 day+1.03%
1 week-4.58%
Current month+6.39%
1 month-9.44%
3 months-25.70%
6 months-60.95%
Current year-79.91%
1 week 1,446
Extreme 1446
1,725
1 month 1,446
Extreme 1446
1,940
Current year 1,446
Extreme 1446
8,490
1 year 1,446
Extreme 1446
9,945
3 years 1,446
Extreme 1446
60,600
5 years 1,446
Extreme 1446
1,55,250
10 years 1,446
Extreme 1446
8,58,000
Manager TitleAgeSince
Chief Executive Officer 63 13/10/2023
Chief Executive Officer 70 01/04/2012
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 70 01/04/2012
Director/Board Member 65 23/03/2020
Director/Board Member 63 13/10/2023
Date Insider Type Main position Quantity % Market Cap. Importance
28/06/24 Exercice

Executive/Senior Manager

6,183 0.0046%
28/06/24 Expiration

Chief Executive Officer

21,884 0.0164%
28/06/24 Exercice 11,846 0.0089% -
Change 5-day change 1-year change 3-year change Capi.($)
+1.03%-4.58%-82.79%-97.19% 1.88Cr
-0.61%-3.43%+36.07%+117.61% 1,01900Cr
-1.02%-5.60%+35.72%+64.82% 62TCr
+1.11%-0.58%+12.36%+78.27% 46TCr
+0.34%-3.01%+61.79%+41.79% 36TCr
-0.95%-4.05%+20.54%+40.33% 33TCr
-1.46%-2.89%+10.57%+26.54% 27TCr
-1.35%-5.43%-6.17%+8.82% 24TCr
-1.04%-2.79%+35.30%+54.42% 22TCr
-1.87%-4.10%+28.44%+97.54% 18TCr
Average -0.58%-3.08%+15.18%+43.29% 36.97TCr
Weighted average by Cap. -0.60%-3.33%+29.07%+71.15%

Financials

2024 2025
Net sales 6.74TCr 5Cr 4.45Cr 4.15Cr 3.78Cr 7.13Cr 480.95Cr 7.2Cr 50Cr 19Cr 245.87Cr 19Cr 18Cr 789.08Cr 7.32TCr 5.44Cr 4.83Cr 4.51Cr 4.11Cr 7.75Cr 522.69Cr 7.82Cr 55Cr 21Cr 267.21Cr 20Cr 20Cr 857.57Cr
Net income -10TCr -7.79Cr -6.93Cr -6.46Cr -5.89Cr -11Cr -749.35Cr -11Cr -78Cr -30Cr -383.08Cr -29Cr -29Cr -1.23TCr -17TCr -13Cr -11Cr -10Cr -9.56Cr -18Cr -1.22TCr -18Cr -126.92Cr -49Cr -621.55Cr -47Cr -46Cr -1.99TCr
Net Debt 12TCr 8.59Cr 7.63Cr 7.12Cr 6.49Cr 12Cr 825.86Cr 12Cr 86Cr 33Cr 422.19Cr 32Cr 32Cr 1.35TCr 18TCr 13Cr 12Cr 11Cr 9.94Cr 19Cr 1.26TCr 19Cr 132.02Cr 51Cr 646.48Cr 49Cr 48Cr 2.07TCr
Logo Aprogen Biologics Inc.
Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
Employees
262
Date Price Change Volume
02/26/02 ₩1,564.00 +1.03% 1,99,501
01/26/01 ₩1,548.00 +5.31% 1,64,250
30/26/30 ₩1,470.00 -2.46% 1,64,231
29/26/29 ₩1,507.00 -3.89% 2,30,861
  1. Stock Market
  2. Stocks
  3. A003060 Stock